How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Press’ post set off a firestorm of controversy within the Haskell community, which is small but vocal, and likely felt the ...
As supply chains continue to evolve, professionals in the industry are faced with the challenges and complexities of creating sustainable supply chains in their organizations. The need to gain ...
The NASCAR Cup Series’ In-Season Challenge returns for its second season in 2026, bringing a five-race, bracket-style tournament to TNT Sports’ portion of the summer schedule. Thirty-two drivers ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results